SCHEMBL6924512

SCHEMBL6924512

CC(C)(C)OC(=O)c1ccc(C(O)(C(=O)O)c2ccccc2)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 2/20 0.51
CYP2D6 P10635 3/20 0.45
TDP1 Q9NUW8 2/20 0.45
HIF1A Q16665 2/20 0.45
TSHR P16473 2/20 0.45
ALDH1A1 P00352 2/20 0.45
HSD17B10 Q99714 1/20 0.45
CA12 O43570 1/20 0.44
CA1 P00915 1/20 0.44
CA2 P00918 1/20 0.44
CA9 Q16790 1/20 0.44
CA14 Q9ULX7 1/20 0.44
MAPT P10636 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
ABCG2 Q9UNQ0 1/20 0.43
TNF P01375 1/20 0.42
KLF5 Q13887 1/20 0.42
NOD1 Q9Y239 1/20 0.42
CYP2C19 P33261 2/20 0.40
CYP1A2 P05177 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6924319 0.86 CYP2C9 (0.42) CYP2C9CYP2D6TDP1HIF1ATSHR
SCHEMBL6924315 0.83 MEN1 (0.48) CYP2D6ALDH1A1CYP2C19CYP1A2NPSR1
SCHEMBL3407954 0.82 TDP1 (0.62) CYP2D6TDP1HIF1ATSHRALDH1A1
SCHEMBL28905894 0.81 CA12 (0.47) CYP2D6TDP1TSHRALDH1A1HSD17B10
SCHEMBL29199324 0.80 TDP1 (0.64) CYP2D6TDP1HIF1ATSHRALDH1A1
Hydrogen Peroxide SCHEMBL28474133 0.80 TDP1 (0.64) CYP2D6TDP1HIF1ATSHRALDH1A1
SCHEMBL260960 0.80 TDP1 (0.64) CYP2D6TDP1HIF1ATSHRALDH1A1
Hydrogen Peroxide SCHEMBL28425777 0.80 TDP1 (0.64) CYP2D6TDP1HIF1ATSHRALDH1A1
SCHEMBL548281 0.79 CA1 (0.51) TDP1TSHRALDH1A1HSD17B10CA12
Hydrochloric Acid SCHEMBL23276979 0.79 TDP1 (0.62) CYP2D6TDP1HIF1ATSHRALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6515011-B2 Anticoagulants MERCK & CO., INC. 2003-02-04 US disclosed
US-20020119992-A1 Thrombin inhibitors MERCK & CO., INC. 2002-08-29 US disclosed
WO-2002050056-A1 BENZYLAMINE DERIVATIVES AND THEIR USE AS THROMBIN INHIBITORS MERCK & CO., INC. (US) 2002-06-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020119992-A1 Thrombin inhibitors SERPINC1, F2, TFPI CYP2C9 1027/4885CYP2D6 3676/4885TDP1 2220/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.